MARKET

AFIB

AFIB

Acutus Medical, Inc.
NASDAQ
0.1919
-0.0061
-3.08%
Opening 12:47 03/28 EDT
OPEN
0.1930
PREV CLOSE
0.1980
HIGH
0.1930
LOW
0.1876
VOLUME
85.42K
TURNOVER
0
52 WEEK HIGH
1.090
52 WEEK LOW
0.1600
MARKET CAP
5.62M
P/E (TTM)
-0.1712
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at AFIB last week (0318-0322)?
Weekly Report · 3d ago
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Peraso Inc. Fell sharply after the company reported worse-than-expected fourth-quarter EPS results. Ontrak, Inc. Shares climbed 197.8% to $0.5660 in Tuesday's mid-day session. Fusion Pharmaceuticals Inc. Gained 97.3% after agreeing to be acquired by AstraZeneca.
Benzinga · 03/19 17:48
12 Health Care Stocks Moving In Tuesday's Intraday Session
Ontrak (NASDAQ:OTRK) shares increased by 97.6% to $0.38 during Tuesday's regular session. Fusion Pharmaceuticals stock moved upwards by 97%. SCWorx stock rose 70.74% and Enliven Therapeutics stock increased by 29.19%. Acutus Medical stock declined by 26.5% during the session.
Benzinga · 03/19 17:31
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Ontrak (NASDAQ:OTRK) shares rose 173.2% to $0.52 during Tuesday's pre-market session. Fusion Pharmaceuticals and Enveric Biosciences moved upwards by 97.46% and 39.09% respectively. Losers include Seelos Therapeutics and Acurx Pharmaceuticals.
Benzinga · 03/19 13:05
Why Fusion Pharmaceuticals Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
Shares of Fusion Pharmaceuticals Inc. Rose sharply in today's pre-market trading. The company agreed to be acquired by AstraZeneca for around $2 billion in cash. Ontrak, Inc. Shares rose 84.2% to $0.35 in pre- market trading.
Benzinga · 03/19 12:10
12 Health Care Stocks Moving In Monday's After-Market Session
Ontrak (NASDAQ:OTRK) stock increased by 61.0% to $0.31 during Monday's after-market session. Universe Pharmaceuticals (NASdaq:UPC) shares rose 30.26% in the same session. Augmedix and Sophia Genetics also moved upwards. Losers Acurx Pharmaceuticals, Acutus Medical and Fresh2 Group were among the names in the losers.
Benzinga · 03/18 21:33
Acutus Medical Has Been Granted European Patent Number EP3294412 Titled "Localization System And Method Useful In The Acquisition And Analysis Of Cardiac Information (For Diagnosis And Treatment Of Cardiac Abnormalities)".
Benzinga · 03/18 19:59
Weekly Report: what happened at AFIB last week (0311-0315)?
Weekly Report · 03/18 09:22
More
About AFIB
Acutus Medical, Inc. is an arrhythmia management company focused on cardiac arrhythmias that are diagnosed and treated. It designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The Company's product is its AcQMap imaging and mapping system, which offers a paradigm-shifting approach to mapping the drivers and maintainers of arrhythmias. It designed AcQMap System to improve procedure efficiency and outcomes by rapidly identifying ablation targets and confirming both ablation success and procedure completion. Its AcQMap System consists of single-use AcQMap catheter, as well as its console, workstation and software algorithms. Its subsidiary is Acutus Medical NV.

Webull offers Acutus Medical Inc stock information, including NASDAQ: AFIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AFIB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AFIB stock methods without spending real money on the virtual paper trading platform.